PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-2.7%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.09B
AUM Growth
+$2.09B
(-16%)
Cap. Flow
-$281M
Cap. Flow
% of AUM
-13.46%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
87
New
5
Increased
22
Reduced
20
Closed
15
Top Buys
| 1 |
Lantheus
LNTH
|
$25.9M |
| 2 |
Veeva Systems
VEEV
|
$16.6M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$13.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$13.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$13.1M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$112M |
| 2 |
Penumbra
PEN
|
$40.5M |
| 3 |
Dynavax Technologies
DVAX
|
$34.9M |
| 4 |
Stryker
SYK
|
$33.6M |
| 5 |
Waters Corp
WAT
|
$25.2M |
Sector Composition
| 1 | Healthcare | 97.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $160M | 7.56% | 298,643 | – | – |
|
2
Humana
HUM
$36.5B
| $80.8M | 3.81% | 166,066 | – | – |
|
3
AbbVie
ABBV
$372B
| $74.7M | 3.52% | 501,192 -3,306 | -0.7% | -$493K |
|
4
Cytokinetics
CYTK
$4.23B
| $70.7M | 3.33% | 2,399,545 | – | – |
|
5
Merck
MRK
$210B
| $61.4M | 2.89% | 596,261 | – | – |
|
|
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
| $59.7M | 2.81% | 281,617 +25,318 | +10% | +$5.37M |
|
7
UnitedHealth
UNH
$281B
| $58.5M | 2.76% | 116,067 | – | – |
|
8
Cardinal Health
CAH
$35.5B
| $55.5M | 2.62% | 639,783 | – | – |
|
9
Centene
CNC
$14.3B
| $54.4M | 2.56% | 789,868 -322,612 | -29% | -$22.2M |
|
10
Icon
ICLR
$13.8B
| $52.6M | 2.48% | 213,559 | – | – |
|
11
argenx
ARGX
$43.6B
| $51.5M | 2.43% | 104,732 | – | – |
|
12
Intuitive Surgical
ISRG
$170B
| $50.3M | 2.37% | 172,043 | – | – |
|
13
Edwards Lifesciences
EW
$47.8B
| $48.7M | 2.29% | 702,588 | – | – |
|
14
Biogen
BIIB
$19.4B
| $48M | 2.26% | 186,635 -11,699 | -6% | -$3.01M |
|
15
Molina Healthcare
MOH
$9.8B
| $47.1M | 2.22% | 143,779 | – | – |
|
|
16
Penumbra
PEN
$10.6B
| $46.5M | 2.19% | 192,406 -167,624 | -47% | -$40.5M |
|
17
iRhythm Technologies
IRTC
$5.46B
| $45.8M | 2.16% | 485,468 | – | – |
|
18
Legend Biotech
LEGN
$6.41B
| $45.6M | 2.15% | 679,076 | – | – |
|
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $44.1M | 2.08% | 498,280 +147,982 | +42% | +$13.1M |
|
20
Danaher
DHR
$147B
| $43.6M | 2.05% | 175,690 | – | – |
|
21
McKesson
MCK
$85.4B
| $42.4M | 2% | 97,498 -8,313 | -8% | -$3.61M |
|
22
Prothena Corp
PRTA
$441M
| $40.4M | 1.9% | 836,571 +62,025 | +8% | +$2.99M |
|
23
Becton Dickinson
BDX
$55.3B
| $39.8M | 1.88% | 153,955 | – | – |
|
24
IQVIA
IQV
$32.4B
| $39.6M | 1.86% | 201,037 | – | – |
|
25
Syndax Pharmaceuticals
SNDX
$1.41B
| $39.4M | 1.86% | 2,715,235 +542,798 | +25% | +$7.88M |
|